CEN Biotech, Inc.
CENBF
$0.0001
$0.000.00%
| 09/30/2022 | 06/30/2022 | ||||
|---|---|---|---|---|---|
| Revenue | -74.95% | 59.42% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -74.95% | 59.42% | |||
| Cost of Revenue | -- | -- | |||
| Gross Profit | -74.95% | 59.42% | |||
| SG&A Expenses | -26.15% | 75.48% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | -26.15% | 75.48% | |||
| Operating Income | -62.13% | -114.44% | |||
| Income Before Tax | -14.90% | -34.53% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | -14.90% | -34.53% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | -14.90% | -34.53% | |||
| EBIT | -62.13% | -114.44% | |||
| EBITDA | -3.89% | -497.39% | |||
| EPS Basic | -10.53% | 6.56% | |||
| Normalized Basic EPS | -11.43% | 7.89% | |||
| EPS Diluted | -10.53% | 6.56% | |||
| Normalized Diluted EPS | -11.43% | 7.89% | |||
| Average Basic Shares Outstanding | 4.32% | 44.61% | |||
| Average Diluted Shares Outstanding | 4.32% | 44.61% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||
